Works matching IS 10781552 AND DT 2013 AND VI 19 AND IP 3

Results: 17

Comparing clinicians’ use of an anticoagulation management service and usual care in ambulatory oncology.

Published in:

2013

By:

Weingart, Saul N;
Cleary, Angela;
Scullion, Bridget;
Morway, Laurinda;
Phantumvanit, Victor;
Stuver, Sherri O;
Shulman, Lawrence N;
Connors, Jean M

Publication type:

Journal Article

Gemcitabine-induced gouty arthritis attacks.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 284, doi. 10.1177/1078155212464893

By:

Bottiglieri, Sal;
Tierson, Neil;
Patel, Raina;
Mo, Jae-Hyun;
Mehdi, Syed

Publication type:

Article

Comparing clinicians’ use of an anticoagulation management service and usual care in ambulatory oncology.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 237, doi. 10.1177/1078155212464892

By:

Weingart, Saul N;
Cleary, Angela;
Scullion, Bridget;
Morway, Laurinda;
Phantumvanit, Victor;
Stuver, Sherri O;
Shulman, Lawrence N;
Connors, Jean M

Publication type:

Article

Efficacy vs. effectiveness: Erlotinib in previously treated non-small-cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 228, doi. 10.1177/1078155212464087

By:

Sheikh, Naureen;
Chambers, Carole R

Publication type:

Article

Severe infusion reactions to brentuximab vedotin in two patients with Hodgkin lymphoma previously treated with allogeneic stem cell transplantation.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 279, doi. 10.1177/1078155212464021

By:

Baxley, Allison A;
Kumm, Debra E;
Bishop, Courtney B;
Medina, Patrick J;
Holter-Chakrabarty, Jennifer

Publication type:

Article

Cetuximab hypersensitivity infusion reactions: Incidence and risk factors*.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 222, doi. 10.1177/1078155212462440

By:

Hopps, Sarah;
Medina, Patrick;
Pant, Shubham;
Webb, Ryan;
Moorman, Meredith;
Borders, Emily

Publication type:

Article

Effectiveness and response predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: A retrospective, observational, multicentric study.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 246, doi. 10.1177/1078155212465994

By:

Cioffi, Pasquale;
Marotta, Valerio;
Fanizza, Caterina;
Giglioni, Adriano;
Natoli, Clara;
Petrelli, Fabio;
Grappasonni, Iolanda

Publication type:

Article

Rounding rituximab dose to nearest vial size.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 218, doi. 10.1177/1078155212462439

By:

Patel, Samit;
Le, Ann

Publication type:

Article

Paronychia induced by the epidermal growth factor receptor inhibitor cetuximab.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 273, doi. 10.1177/1078155212461289

By:

Lee, Soo Lin;
Tan, Boon Seang;
Chan, Lee Chin

Publication type:

Article

Unexpected doxorubicin-mediated cardiotoxicity in sisters: Possible role of polymorphisms in histamine n-methyl transferase.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 269, doi. 10.1177/1078155212461022

By:

Sachidanandam, Kamakshi;
Gayle, Arlene A;
Robins, H Ian;
Kolesar, Jill M

Publication type:

Article

Cetuximab-induced nephrotic syndrome in a case of metastatic rectal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 265, doi. 10.1177/1078155212459668

By:

Ito, Chiharu;
Fujii, Hirofumi;
Ogura, Manabu;
Sato, Hirotake;
Kusano, Eiji

Publication type:

Article

Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 208, doi. 10.1177/1078155212459667

By:

Yuki, Michiko;
Sekine, Satoko;
Takase, Kanae;
Ishida, Takashi;
Sessink, Paul JM

Publication type:

Article

Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 261, doi. 10.1177/1078155212459285

By:

Cherry, Mohamad A;
Bhardwaj, Himanshu;
Hopps, Sarah;
Srour, Samer;
Pant, Shubham

Publication type:

Article

Ipilimumab for advanced melanoma: A pharmacologic perspective.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 195, doi. 10.1177/1078155212459100

By:

Trinh, Van Anh;
Hagen, Brenda

Publication type:

Article

Is there still a role for mitomycin-based combination chemotherapy in treating patients with nonsmall cell lung cancer? A single institution experience.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 202, doi. 10.1177/1078155212458133

By:

Vitale, Felice V;
Malaponte, Emilia;
Calì, Stefania;
Antonelli, Giovanna;
Panebianco, Vincenzo;
Blandino, Rosario;
Ferraù, Francesco

Publication type:

Article

Tyrosine kinase inhibitor induced pancreatitis.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 257, doi. 10.1177/1078155212457968

By:

Sevin, Adrienne;
Chen, Adrienne;
Atkinson, Brad

Publication type:

Article

Isolated hypomagnesemia in a patient treated with capecitabine.

Published in:

Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 254, doi. 10.1177/1078155212455445

By:

Rajapakse, Senaka;
Rodrigo, Chaturaka;
Rajapakse, Anoja C

Publication type:

Article